![PRD_000417 PRD_000417](https://data.pdbj.org/pdbjplus/data/cc/svg/2Z4.svg) | PRD_000417 | Name: | benzyl [(1R)-1-({(1S,2S,3S)-1-benzyl-2-hydroxy-4-({(1S)-1-[(2-hydroxy-4-methoxybenzyl)carbamoyl]-2-methylpropyl}amino)-3-[(4-methoxybenzyl)amino]-4-oxobutyl}carbamoyl)-2,2-dimethylpropyl]carbamate | Formula: | C46 H59 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000418 PRD_000418](https://data.pdbj.org/pdbjplus/data/cc/svg/2Z5.svg) | PRD_000418 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C18 H23 F6 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000419 PRD_000419](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000419.svg) | PRD_000419 | Name: | Acetyl-L-alanyl-L-alanyl-L-phenylalanyl-L-alanine chloromethyl ketone, AcAAPACK | Formula: | C21 H29 Cl N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000420 PRD_000420](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000420.svg) | PRD_000420 | Name: | AC-ARG-GLU-LYS-BOROARG PEPTIDYL BORONIC ACID INHIBITOR | Formula: | C24 H50 B N11 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000421 PRD_000421](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000421.svg) | PRD_000421 | Name: | ACE-PRO-ALA-PRO-PHE-ALDEHYDE | Formula: | C24 H32 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000422 PRD_000422](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000422.svg) | PRD_000422 | Name: | Ac-Asp-Glu-Val-Asp-Aldehyde | Formula: | C20 H32 N4 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000423 PRD_000423](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000423.svg) | PRD_000423 | Name: | N-acetyl-L-leucyl-L-alanyl-N-[(1S)-4-(dimethylamino)-1-(fluoroacetyl)-4-oxobutyl]-L-alaninamide | Formula: | C22 H38 F N5 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000424 PRD_000424](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000424.svg) | PRD_000424 | Name: | ACE-ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARINN | Formula: | C25 H31 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000425 PRD_000425](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000425.svg) | PRD_000425 | Name: | Caspase-2 Inhibitor; Ac-VDVAD-Cho | Formula: | C23 H39 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000426 PRD_000426](https://data.pdbj.org/pdbjplus/data/cc/svg/2ZF.svg) | PRD_000426 | Name: | N-(tert-butoxycarbonyl)-L-alpha-glutamyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide | Formula: | C21 H33 F2 N3 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000427 PRD_000427](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000427.svg) | PRD_000427 | Name: | FIV PROTEASE INHIBITOR LP-149; Ac-NA-Val-Sta-Glu-NA-NH2 | Formula: | C46 H58 N6 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000429 PRD_000429](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000429.svg) | PRD_000429 | Name: | (ACE)APQV(STA)VMHP peptide Inhibitor | Formula: | C49 H81 N12 O13 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000430 PRD_000430](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000430.svg) | PRD_000430 | Name: | H 189 | Formula: | C62 H97 N17 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000431 PRD_000431](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000431.svg) | PRD_000431 | Name: | CASPASE-7 INHIBITOR AC-DMQD-CHO | Formula: | C20 H33 N5 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000432 PRD_000432](https://data.pdbj.org/pdbjplus/data/cc/svg/2ZS.svg) | PRD_000432 | Name: | N-(morpholin-4-ylcarbonyl)-L-phenylalanyl-N-[(1R,2S)-1-(cyclohexylmethyl)-2-hydroxy-3-(1-methylethoxy)-3-oxopropyl]-S-methyl-L-cysteinamide | Formula: | C31 H48 N4 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000434 PRD_000434](https://data.pdbj.org/pdbjplus/data/cc/svg/3TL.svg) | PRD_000434 | Name: | benzyl [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-dibenzyl-8,9-dihydroxy-1,16-dimethyl-4,13-bis(1-methylethyl)-2,5,12,15,18-pentaoxo-20-phenyl-19-oxa-3,6,11,14,17-pentaazaicos-1-yl]carbamate | Formula: | C50 H64 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000439 PRD_000439](https://data.pdbj.org/pdbjplus/data/cc/svg/AZ0.svg) | PRD_000439 | Name: | ethyl (5S,8S,14S)-14-hydroxy-5,8,11-tris(2-methylpropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadecan-15-oate | Formula: | C30 H48 N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000444 PRD_000444](https://data.pdbj.org/pdbjplus/data/cc/svg/EP2.svg) | PRD_000444 | Name: | methyl N-[(2S)-4-{[(1S)-1-{[(2S)-2-carboxypyrrolidin-1-yl]carbonyl}-3-methylbutyl]amino}-2-hydroxy-4-oxobutanoyl]-L-leucylglycylglycinate | Formula: | C26 H41 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000451 PRD_000451](https://data.pdbj.org/pdbjplus/data/cc/svg/MID.svg) | PRD_000451 | Name: | 1-[N-(naphthalen-2-ylsulfonyl)glycyl-4-carbamimidoyl-D-phenylalanyl]piperidine | Formula: | C27 H31 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000452 PRD_000452](https://data.pdbj.org/pdbjplus/data/cc/svg/MIT.svg) | PRD_000452 | Name: | amino{[(4S)-5-[(2R,4R)-2-carboxy-4-methylpiperidin-1-yl]-4-({[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}amino)-5-oxopentyl]amino}methaniminium | Formula: | C23 H37 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000453 PRD_000453](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000453.svg) | PRD_000453 | Name: | N-[3-(1H-benzimidazol-1-yl)propanoyl]glycyl-L-alanyl-L-alaninamide | Formula: | C18 H24 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000454 PRD_000454](https://data.pdbj.org/pdbjplus/data/cc/svg/ROC.svg) | PRD_000454 | Name: | (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1
-phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide | Formula: | C38 H50 N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000457 PRD_000457](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000457.svg) | PRD_000457 | Name: | INHIBITOR CH2-QLTSNV-Z (SUBSTRATE-ANALOG) | Formula: | C36 H55 Cl N8 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000459 PRD_000459](https://data.pdbj.org/pdbjplus/data/cc/svg/TCK.svg) | PRD_000459 | Name: | N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide | Formula: | C14 H21 Cl N2 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000465 PRD_000465](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000465.svg) | PRD_000465 | Name: | Argifin | Formula: | C29 H41 N9 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|